Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Adenocarcinoma 1

Interventions

Specimen Handling 74Fluorouracil 72Oxaliplatin 64Leucovorin 55Magnetic Resonance Spectroscopy 52Bevacizumab 48Gemcitabine 41Biopsy 40Capecitabine 38Nivolumab 31Irinotecan 31Cisplatin 30pembrolizumab 28durvalumab 28Cetuximab 22Paclitaxel 20dehydroftorafur 19Folfox protocol 19atezolizumab 18130-nm albumin-bound paclitaxel 16Radiotherapy 15Radiation 15Taxes 14Carboplatin 13Albumin-Bound Paclitaxel 13tremelimumab 11X-Rays 11Surgical Procedures, Operative 11trastuzumab deruxtecan 10lenvatinib 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
paricalcitol × Gastrointestinal × 30 days × Clear all
NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed
34 enrolled 11 charts
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡